Higher immunoreactivity for FASN, p-AKT, and c-Met proteins was found in 90.4%, 59.6%, and 28.7% of HCC specimens, respectively, when compared with surrounding non-tumorous liver tissue. This evidence concerns the gene MET and hepatocellular carcinoma.